Published in Hepatology on October 01, 1995
Guidelines on the management of ascites in cirrhosis. Gut (2006) 1.81
Spontaneous bacterial peritonitis. World J Gastroenterol (2009) 1.15
Primary and secondary peritonitis: an update. Eur J Clin Microbiol Infect Dis (1998) 0.99
Diagnosis and therapy of ascites in liver cirrhosis. World J Gastroenterol (2011) 0.99
Diagnosis and management of bacterial infections in decompensated cirrhosis. World J Hepatol (2013) 0.99
Clinical features and prognosis of spontaneous bacterial peritonitis in korean patients with liver cirrhosis: a multicenter retrospective study. Gut Liver (2009) 0.97
Spontaneous bacterial peritonitis: The clinical challenge of a leaky gut and a cirrhotic liver. World J Hepatol (2015) 0.93
Antimicrobial prophylaxis in adults. Mayo Clin Proc (2011) 0.88
Improving survival in decompensated cirrhosis. Int J Hepatol (2012) 0.86
Spontaneous bacterial peritonitis. Postgrad Med J (2007) 0.83
Prevention and management of bacterial infections in cirrhosis. Int J Hepatol (2011) 0.82
Daily norfloxacin is more effective than weekly rufloxacin in prevention of spontaneous bacterial peritonitis recurrence. Dig Dis Sci (2002) 0.80
Daily ciprofloxacin treatment for patients with advanced liver disease awaiting liver transplantation reduces hospitalizations. Dig Dis Sci (2010) 0.79
Impact of prolonged treatment with high-dose ciprofloxacin on human gut flora: a case report. J Med Case Rep (2010) 0.79
Ascites. Curr Treat Options Gastroenterol (2001) 0.76
Ascites and spontaneous bacterial peritonitis: recommendations from two United States centers. Saudi J Gastroenterol (2014) 0.76
Management of the Cirrhotic Patient Before Liver Transplantation: The Role of the Referring Gastroenterologist. Gastroenterol Hepatol (N Y) (2006) 0.75
Testing beneficial therapy in human cirrhosis using animal models of cirrhosis. Dig Dis Sci (2011) 0.75
Ciprofloxacin: Spontaneous Bacterial Peritonitis (Prevention). Hosp Pharm (2015) 0.75
Aminoglycoside antibiotics restore dystrophin function to skeletal muscles of mdx mice. J Clin Invest (1999) 3.06
An in-depth study of Crohn's disease in two French families. Gastroenterology (1993) 2.15
Specific pruritic diseases of pregnancy. A prospective study of 3192 pregnant women. Arch Dermatol (1994) 1.90
Differential requirement for individual sarcoglycans and dystrophin in the assembly and function of the dystrophin-glycoprotein complex. J Cell Sci (2000) 1.86
Characteristics of patients with dual infection by hepatitis B and C viruses. J Hepatol (1998) 1.84
Hepatic iron overload: diagnosis and quantification with MR imaging. AJR Am J Roentgenol (1997) 1.74
Treatment of diversion colitis by short-chain fatty acids. Prospective and double-blind study. Dis Colon Rectum (1991) 1.65
Latent pulmonary involvement in Crohn's disease: biological, functional, bronchoalveolar lavage and scintigraphic studies. Gut (1986) 1.63
Perioperative endoscopy of the whole small bowel in Crohn's disease. Gut (1993) 1.54
The changing relative prevalence of hepatitis C virus genotypes: evidence in hemodialyzed patients and kidney recipients. Gastroenterology (1995) 1.54
[Neuromeningeal listeriosis in adults. Clinical aspects and contribution of cotrimoxazole in monotherapy]. Presse Med (1993) 1.49
Orthotopic liver transplantation for incurable alveolar echinococcosis of the liver: report of 17 cases. Hepatology (1991) 1.39
Evaluation and improvement of a reliable diagnosis of cirrhosis by blood tests. Gastroenterol Clin Biol (2008) 1.39
Evidence for sub-picosecond heme doming in hemoglobin and myoglobin: a time-resolved resonance Raman comparison of carbonmonoxy and deoxy species. Biochemistry (1995) 1.38
T-state hemoglobin with four ligands bound. Biochemistry (1988) 1.37
Eosinophilic gastroenteritis: ultrastructural evidence for a selective release of eosinophil major basic protein. Clin Exp Immunol (1988) 1.29
Ultrastructural and physicochemical characterization of the hepatitis C virus recovered from the serum of an agammaglobulinemic patient. Arch Virol (1998) 1.28
Palliative treatment of rectosigmoid carcinoma by laser endoscopic photoablation. Gastroenterology (1987) 1.27
Antiretroviral treatment and age-related comorbidities in a cohort of older HIV-infected patients. HIV Med (2006) 1.24
Muscle degeneration without mechanical injury in sarcoglycan deficiency. Proc Natl Acad Sci U S A (1999) 1.23
Two successive hepatitis C virus infections in an intravenous drug user. J Clin Microbiol (2000) 1.20
[Clinical trial of an antipneumococcal vaccine in elderly subjects living in institutions]. Rev Epidemiol Sante Publique (1985) 1.19
New effectors of human hemoglobin: structure and function. Biochemistry (1990) 1.19
Decrease in serum ALT and increase in serum HCV RNA during pregnancy in women with chronic hepatitis C. J Hepatol (2000) 1.15
Comparative analysis of two assays for genotyping hepatitis C virus based on genotype-specific primers or probes. J Hepatol (1995) 1.14
Tenoxicam, a non-steroid anti-inflammatory drug, is unable to increase the response rate in patients with chronic hepatitis C treated by alpha interferon. Hepatology (1998) 1.13
Epidemiology and course of acute upper gastro-intestinal haemorrhage in four French geographical areas. Eur J Gastroenterol Hepatol (2000) 1.12
Impaired bacterial flora in human excluded colon. Gut (1989) 1.12
Transjugular intrahepatic portosystemic shunt in refractory ascites: a meta-analysis. Liver Int (2005) 1.10
Villous adenomas of the rectum. Results of endoscopic treatment with argon and Nd:YAG lasers. Gastroenterology (1985) 1.09
Bacterial translocation in colorectal cancers. Gastroenterol Clin Biol (1990) 1.04
Noninvasive imaging of insulinomas and gastrinomas with endoscopic ultrasonography and somatostatin receptor scintigraphy. Surgery (1998) 1.01
Antineutrophil cytoplasmic autoantibodies in inflammatory bowel diseases. Gastroenterol Clin Biol (1992) 1.01
The kinetics of antibodies against hepatitis C virus may predict viral clearance in exposed hemophiliacs. J Infect Dis (1998) 1.00
Evidence of lymphocyte alveolitis in Crohn's disease. Chest (1985) 1.00
Effectors of hemoglobin. Separation of allosteric and affinity factors. Biophys J (1990) 0.99
Prevalence and significance of hepatitis C virus (HCV) viremia in HCV antibody-positive subjects from various populations. J Clin Microbiol (1993) 0.99
Coupling of ferric iron spin and allosteric equilibrium in hemoglobin. Biophys J (1991) 0.98
A second heterozygous MDR3 nonsense mutation associated with intrahepatic cholestasis of pregnancy. J Med Genet (2003) 0.97
Gene therapy using adenovirus vectors. Curr Top Microbiol Immunol (1995) 0.97
Percutaneous transhepatic embolization of gastroesophageal varices: results in 400 patients. AJR Am J Roentgenol (1989) 0.97
Anti-inflammatory drugs and variceal bleeding: a case-control study. Gut (1999) 0.96
Pneumocystis jirovecii (Pj) quantitative PCR to differentiate Pj pneumonia from Pj colonization in immunocompromised patients. Eur J Clin Microbiol Infect Dis (2013) 0.95
Treatment of hepatocellular carcinoma by transcatheter arterial chemoembolization: comparison of planned periodic chemoembolization and chemoembolization based on tumor response. AJR Am J Roentgenol (1999) 0.95
Evaluation of efficacy of liver transplantation in alcoholic cirrhosis by a case-control study and simulated controls. Lancet (1994) 0.95
A case of myiasis in man due to Wohlfahrtia magnifica (Schiner) recorded near Rome. Parassitologia (1999) 0.95
Treatment of pain from osteoporotic vertebral collapse by percutaneous PMMA vertebroplasty. Acta Neurochir (Wien) (2004) 0.93
LacZ gene transfer into tumor cells abrogates tumorigenicity and protects mice against the development of further tumors. Gene Ther (1996) 0.93
Endoscopic palliation for inoperable malignant dysphagia: long term follow up. Gut (1992) 0.92
Protein-energy malnutrition in elderly medical patients. J Am Geriatr Soc (1992) 0.92
Internal radiation therapy for hepatocellular carcinoma. Results of a French multicenter phase II trial of transarterial injection of iodine 131-labeled Lipiodol. Cancer (1992) 0.92
Steric and hydrophobic determinants of the solubilities of recombinant sickle cell hemoglobins. Protein Sci (1992) 0.92
Infection of aortic aneurysm with Coxiella burnetii. Lancet (1991) 0.92
Is intravenous administration of branched chain amino acids effective in the treatment of hepatic encephalopathy? A multicenter study. Hepatology (1983) 0.91
TP53 gene mutation profile in esophageal squamous cell carcinomas. Cancer Res (1993) 0.91
[Hepatonephritis and massive ingestion of buprenorphine]. Acta Clin Belg Suppl (1999) 0.89
Enhanced polymerization of recombinant human deoxyhemoglobin beta 6 Glu----Ile. Proc Natl Acad Sci U S A (1990) 0.89
Interferon-gamma releasing assay versus tuberculin skin testing for latent tuberculosis infection in targeted screening programs for high risk immigrants. Infection (2010) 0.89
Penetration of sulbactam into the cerebrospinal fluid of patients with bacterial meningitis receiving ampicillin therapy. Rev Infect Dis (1987) 0.88
Antibody response of patients with Helicobacter pylori-related gastric adenocarcinoma: significance of anti-cagA antibodies. Clin Diagn Lab Immunol (2000) 0.88
Caroli's disease: a magnetic resonance cholangiopancreatography diagnosis. Am J Gastroenterol (1998) 0.88
ABCB4 gene mutations and single-nucleotide polymorphisms in women with intrahepatic cholestasis of pregnancy. J Med Genet (2009) 0.88
Appropriateness of blood culture testing parameters in routine practice. Results from a cross-sectional study. Eur J Clin Microbiol Infect Dis (2010) 0.88
Review article: the utility of reagent strips in the diagnosis of infected ascites in cirrhotic patients. Aliment Pharmacol Ther (2008) 0.87
Direct evidence for the role of haem doming as the primary event in the cooperative transition of haemoglobin. Nat Struct Biol (1994) 0.87
Liver fibrosis staging with contrast-enhanced ultrasonography: prospective multicenter study compared with METAVIR scoring. Eur Radiol (2009) 0.87
[The articular manifestations of Whipple's disease. Apropos of a case, with histological study of the synovial membrane]. Sem Hop (1974) 0.87
[Value of transient elastography in noninvasive assessment in children's hepatic fibrosis]. Arch Pediatr (2009) 0.86
p53 protein accumulation in oesophageal squamous cell carcinomas and precancerous lesions. J Clin Pathol (1995) 0.86
[Paraduodenal cysts near Vater's ampulla and chronic pancreatitis]. Med Chir Dig (1975) 0.86
[Immune and autoimmune manifestations of autochthonous visceral leishmaniasis with liver, kidney and vascular involvement]. Bull Soc Pathol Exot Filiales (1983) 0.86
[Flow cytometric analysis of cellular DNA content in Barret's esophagus. A study of 66 cases]. Gastroenterol Clin Biol (1991) 0.86
[Treatment of and survival after epidermoid cancer of the esophagus in the department of Finistère between 1984 and 1988 (716 cases)]. Gastroenterol Clin Biol (1993) 0.86
Non-O1, non-O139 Vibrio cholerae bacteraemia in a cirrhotic patient. J Med Microbiol (2010) 0.85
The protein kinase-interacting domain in the hepatitis C virus envelope glycoprotein-2 gene is highly conserved in genotype 1-infected patients treated with interferon. J Infect Dis (2000) 0.85
[Incidence of inflammatory bowel disease in the Nord-Pas-de-Calais region and the Somme area of France in 1988]. Gastroenterol Clin Biol (1990) 0.85
Flow cytometry: a novel approach for the quantitative analysis of receptor--ligand interactions on surfaces of living cells. Mol Cell Endocrinol (1980) 0.85
Association of an attack of varicella and an achalasia. Am J Gastroenterol (1995) 0.85
Failure of teicoplanin treatment associated with an increase in MIC during therapy of Staphylococcus aureus septicaemia. J Antimicrob Chemother (1992) 0.85
Diffusion of ofloxacin into the cerebrospinal fluid in patients with bacterial meningitis. Infection (1986) 0.85
Prospective assessment of fluoroquinolone use in a teaching hospital. Eur J Clin Microbiol Infect Dis (2006) 0.85
Adenoviral interleukin-2 gene transfer into P815 tumor cells abrogates tumorigenicity and induces antitumoral immunity in mice. Hum Gene Ther (1993) 0.84
An estimation of the first binding constant of O2 to human hemoglobin A. Eur J Biochem (1978) 0.84
[Blue rubber bleb nevus syndrome. 3 cases treated with a Nd:YAG laser and bipolar electrocoagulation]. Gastroenterol Clin Biol (1990) 0.84
Superoxide anion generation by alveolar macrophages in Crohn's disease. N Engl J Med (1985) 0.84
Epidemiology of infectious encephalitis, differences between a prospective study and hospital discharge data. Epidemiol Infect (2012) 0.84
[The frozen shoulder. Arthroscopy, histological findings and transmission electron microscopy imaging]. Chirurg (2001) 0.84
Transient elastography and portal hypertension in pediatric patients with cystic fibrosis Transient elastography and cystic fibrosis. J Cyst Fibros (2011) 0.84
Plasmodium berghei development in irradiated sporozoite-immunized C57BL6 mice. Parasitology (1999) 0.83
[Severe erythema multiforme and hepatitis during treatment with trimebutine]. Gastroenterol Clin Biol (1989) 0.83
[Comparative effectiveness of ranitidine (150 mg X 2) and cimetidine (400 mg x 2) in the treatment of acute duodenal ulcer. A French multicenter controlled clinical trial]. Gastroenterol Clin Biol (1987) 0.83
Phenotype-genotype correlation in haemochromatosis subjects. Hum Genet (1997) 0.83
Familial Crohn's disease in multiple siblings: no linkage to the HLA system. Gastroenterol Clin Biol (1989) 0.83
The microbiological diagnosis of tuberculous meningitis: results of Haydarpasa-1 study. Clin Microbiol Infect (2014) 0.83
[Gastric conservation in severe caustic lesions of the digestive tract: is it legitimate?]. Ann Chir (2003) 0.82
Endoscopic laser treatment for rectosigmoid villous adenoma: factors affecting the results. Gastroenterology (1989) 0.81
Molecular analysis of the TP53 gene in Barrett's adenocarcinoma. Hum Mutat (1996) 0.81
Cutaneous cryptococcosis resembling molluscum contagiosum: a first manifestation of AIDS. Acta Derm Venereol (1989) 0.81
IL-2 gene delivery within an established murine tumor causes its regression without proliferation of preexisting antitumor-specific CTL. J Immunol (1997) 0.81